We worked with dermatologists to find the best acne treatments. Our top picks include prescription tretinoin cream and oral antibiotics as well as OTC salicylic acid toners and niacinamide serums.

The partners did not reveal specific data in their news release, only announcing that Tezspire resulted in a “statistically significant and clinically meaningful” decrease in the size of nasal polyps.

There are several barriers to mental health treatment for minority populations. Barriers can reduce or prevent access to effective care, leading to negative mental health outcomes. Several ...

Amanda Gardner is a freelance health reporter whose stories have appeared in cnn.com, health.com, cnn.com, WebMD, HealthDay, Self Magazine, the New York Daily News, Teachers & Writers Magazine ...

AstraZeneca (NASDAQ:AZN) and Amgen (NASDAQ:AMGN) have announced positive outcomes from the Phase III WAYPOINT trial of TEZSPIRE (tezepelumab) for patients with severe chronic rhinosinusitis with nasal ...

“Patients diagnosed with nasal polyps continue to experience significant burden including repeat surgeries and frequent treatment with high doses of oral corticosteroids, which are associated ...

"The tezepelumab data are clinically meaningful and offer patients with nasal polyps hope for a potential new treatment option that may reduce the burden on patients and healthcare systems," said ...

(Alliance News) - AstraZeneca PLC on Friday said it received positive results from a trial of Tezspire as a treatment for chronic rhinosinusitis with nasal polyps. Chronic rhinosinusitis is a ...

(Alliance News) - AstraZeneca PLC on Friday said it received positive results from a trial of Tezspire as a treatment for chronic rhinosinusitis with nasal polyps. Chronic rhinosinusitis is a disorder ...

Participants in the trial were symptomatic despite treatment with standard of care (intranasal corticosteroids [INCS]). Chronic rhinosinusitis with nasal polyps is a condition that can cause ...

Amgen (AMGN) and AstraZeneca (AZN) announced top-line results from the Phase 3 WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps ... despite treatment with standard of ...